Cargando…
Kinase inhibitors in the treatment of immune-mediated disease
Protein kinases are fundamental components of diverse signaling pathways, including immune cells. Their essential functions have made them effective therapeutic targets. Initially, the expectation was that a high degree of selectivity would be critical; however, with time, the use of “multikinase” i...
Autores principales: | Kontzias, Apostolos, Laurence, Arian, Gadina, Massimo, O’Shea, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297200/ https://www.ncbi.nlm.nih.gov/pubmed/22403586 http://dx.doi.org/10.3410/M4-5 |
Ejemplares similares
-
Protein kinases: drug targets for immunological disorders
por: Castelo-Soccio, Leslie, et al.
Publicado: (2023) -
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
por: Alexander, Madison, et al.
Publicado: (2021) -
JAK Kinases in Health and Disease: An Update
por: Laurence, Arian, et al.
Publicado: (2012) -
Reversal of CD8 T-Cell–Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib
por: Okiyama, Naoko, et al.
Publicado: (2014) -
New insights on multigenic autoinflammatory diseases
por: Efthimiou, Petros, et al.
Publicado: (2022)